|[March 20, 2017]
ANTH INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Anthera Pharmaceuticals, Inc. and a Lead Plaintiff Deadline of April 17, 2017
The Law Offices of Vincent Wong announce that a class action lawsuit has
been commenced in the USDC for the Northern District of California on
behalf of investors who purchased Anthera Pharmaceuticals, Inc.
(NASDAQ:ANTH) securities between February 10, 2015 and December 27, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/anthera-pharmaceuticals-inc.
There is no cost or obligation to you.
According to the complaint, throughout the Class Period Anthera made
materially false and/or misleading statements concerning the potential
efficacy and success of its Solution Study and CHABLIS-SC1 clinical
trials, as the Company failed to disclose that: (i) patients were not
improving in the CHABLIS-SC1 clinical trial; and (ii) thre were dosing
problems inherent in the Solution Study design that created challenges
to obtaining responses.
On November 10, 2016, the Company issued a press release announcing that
the CHABLIS-SC1 clinical trial with blisibimod for the treatment of SLE
failed to meet its primary endpoint. Following this news, shares of
Anthera fell approximately 32% to close at $1.90 on November 10, 2016.
Then on December 27, 2016, the Company issued another press release,
announcing that the Solution clinical study in cystic fibrosis patients
with EPI missed the CFA non-inferiority margin of the primary modified
Intent to Treat. Following this news, shares of Anthera fell
approximately 63% to close at $0.74 on December 28, 2016.
If you suffered a loss in Anthera you have until April 17, 2017 to
request that the Court appoint you as lead plaintiff. Your ability to
share in any recovery doesn't require that you serve as a lead
plaintiff. To obtain additional information, contact Vincent Wong, Esq.
either via email email@example.com, by
telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/anthera-pharmaceuticals-inc.
Vincent Wong, Esq. is an experienced attorney that has represented
investors in securities litigations involving financial fraud and
violations of shareholder rights. Attorney advertising. Prior results do
not guarantee similar outcomes.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170320005744/en/
[ Back To TMCnet.com's Homepage ]